Predictive value of biomarkers for the risk of dementia and vascular dementia in patients with vascular risk factors
Project/Area Number |
15K19227
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Epidemiology and preventive medicine
|
Research Institution | Osaka University |
Principal Investigator |
Miwa Kaori 大阪大学, 医学部附属病院, 医員 (80645341)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 認知症 / 脳小血管病 / 白質病変 / ホモシステイン / インターロイキン6 / CRP 遺伝多型 / IL6R 遺伝多型 / 脂肪酸 / 認知機能障害 / オメガ脂肪酸 / mild parkinsonian sign / 椎骨動脈径拡大 / 新規バイオマーカー / 国際学会参加 / マトリックスメタロプロティナーゼ / MRI |
Outline of Final Research Achievements |
We aimed to investigate the predictive value of baseline interleukin-6 (IL-6), C-reactive protein (CRP) and gene variants [IL-6 receptor (IL-6R), rs2228145; IL-6, rs2097677; CRP, rs3093059] for dementia risk in patients with vascular risk factors who are initially cognitively intact. In multivariable analyses adjusted for covariates and IL-6R variant (rs2228145), IL-6 levels for dementia remained significant. Although subjects with rs2228145 carrier had significantly higher IL-6 levels, a significant association between rs2228145 and dementia was not observed. We also explored the predictive value of baseline homocysteine or circulating levels of eicosapentaenoic acid, docosahexaenoic acid [DHA], dihomo-γ-linolenic acid, and arachidonic acid for dementia risk. The effect of IL-6, homocysteine, or DHA for dementia risk remain consistent irrespective of conventional risk factors including apolipoprotein Eε4, cerebral small-vessel disease and brain atrophy.
|
Report
(3 results)
Research Products
(7 results)